A federal jury delivered a significant verdict in favor of the counterclaimant, awarding $115 million in a patent trial concerning a muscular dystrophy drug. The trial, presided over by U.S. District Judge Jennifer L. Hall, spanned over five days. Legal representation for the successful counterclaimant was provided by the law firms Latham & Watkins and Finnegan, Henderson, Farabow, Garrett & Dunner. The trial’s focus was centered on the patent rights for a drug used in the treatment of muscular dystrophy.
For further details on the trial proceedings and the implications of this verdict, additional information can be found in the original article.